Liraglutide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Liraglutide Injection (injection) from Novo Nordisk, Inc. with status To Be Discontinued. The shortage was first posted on Aug 25, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Novo Nordisk, Inc.
- Package NDC
- 0169-2800-15
- Dosage Form
- Injection
- Presentation
- Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
- Initial Posting
- Aug 25, 2026